期(qi)刊中文名:糖(tang)尿病ISSN:2072-0351E-ISSN:2072-0378
該雜志國際(ji)(ji)(ji)簡稱:DIABETES MELLIT,是由出版(ban)商Endocrinology Research Centre出版(ban)的一(yi)本(ben)致(zhi)力(li)于發(fa)布--研(yan)究新成(cheng)果的的專業學術(shu)期刊。主要(yao)發(fa)表刊登有創見的學術(shu)論文(wen)文(wen)章、行(xing)業最新科(ke)研(yan)成(cheng)果,扼要(yao)報(bao)道(dao)階段性研(yan)究成(cheng)果和重要(yao)研(yan)究工(gong)作的最新進(jin)展(zhan),選載對學科(ke)發(fa)展(zhan)起指(zhi)導作用的綜述與專論,促進(jin)學術(shu)發(fa)展(zhan),為廣大讀者服務。該刊是一(yi)本(ben)國際(ji)(ji)(ji)優(you)秀(xiu)雜志,在國際(ji)(ji)(ji)上有很高的學術(shu)影響(xiang)力(li)。
《Diabetes Mellitus》是一本(ben)以English/Russian為主的(de)(de)開放獲取(qu)國際(ji)優秀期刊,中文(wen)名稱(cheng)糖尿病,本(ben)刊主要出版、報(bao)道(dao)領(ling)域(yu)的(de)(de)研究(jiu)動態以及在該領(ling)域(yu)取(qu)得的(de)(de)各方面(mian)的(de)(de)經(jing)驗和(he)科研成果,介紹該領(ling)域(yu)有(you)關本(ben)專(zhuan)業的(de)(de)最新(xin)進展(zhan)(zhan)(zhan),探討行(xing)業發展(zhan)(zhan)(zhan)的(de)(de)思路(lu)和(he)方法,以促進學(xue)術(shu)信息(xi)交流(liu),提高行(xing)業發展(zhan)(zhan)(zhan)。該刊已(yi)被國際(ji)權威數據庫(ku)SCIE收錄,為該領(ling)域(yu)相關學(xue)科的(de)(de)發展(zhan)(zhan)(zhan)起到了(le)良(liang)好的(de)(de)推動作(zuo)用,也得到了(le)本(ben)專(zhuan)業人員的(de)(de)廣泛認(ren)可。該刊最新(xin)影響因子為0.7,最新(xin)CiteScore 指數為1.9。
Diabetes Mellitus is a research-oriented academic journal focusing on diabetes and its related complications. It is committed to providing a communication platform for researchers, clinicians and public health experts in the field of diabetes, and promoting the dissemination of the latest research results in the prevention, diagnosis, treatment and management of diabetes. The journal aims to promote scientific development in the field of diabetes and provide strong support for clinical practice by publishing high-quality research results. The journal covers many aspects of diabetes research, including but not limited to basic scientific research, clinical research, epidemiological investigation, genetic analysis, drug development and evaluation, nutrition and exercise intervention, and the impact of psychosocial factors. It not only reports the latest scientific findings, but also discusses strategies and technological innovation for improving the quality of life of diabetes patients.
按(an)JIF指標學(xue)科(ke)分區 |
學科:ENDOCRINOLOGY & METABOLISM
收錄子集:ESCI
分區:Q4
排名:164 / 186
百分位:
12.1% |
按JCI指標(biao)學科分區 |
學科:ENDOCRINOLOGY & METABOLISM
收錄子集:ESCI
分區:Q4
排名:177 / 186
百分位:
5.11% |
JCR分區:JCR分(fen)區(qu)來自科(ke)睿唯安(an)公(gong)司(si),JCR是(shi)一個獨特的(de)(de)(de)(de)多學科(ke)期(qi)(qi)刊(kan)(kan)評價工具,為(wei)唯一提供基(ji)于引(yin)文(wen)數據的(de)(de)(de)(de)統計信息的(de)(de)(de)(de)期(qi)(qi)刊(kan)(kan)評價資源。每年發布的(de)(de)(de)(de)JCR分(fen)區(qu),設置了254個具體學科(ke)。JCR分(fen)區(qu)根據每個學科(ke)分(fen)類按照期(qi)(qi)刊(kan)(kan)當年的(de)(de)(de)(de)影(ying)響(xiang)因子高低將期(qi)(qi)刊(kan)(kan)平均分(fen)為(wei)4個區(qu),分(fen)別為(wei)Q1、Q2、Q3和(he)Q4,各占(zhan)25%。JCR分(fen)區(qu)中(zhong)期(qi)(qi)刊(kan)(kan)的(de)(de)(de)(de)數量(liang)是(shi)均勻分(fen)為(wei)四個部分(fen)的(de)(de)(de)(de)。
學科類別 | 分區 | 排名 | 百分位 |
大類:Medicine 小類:Internal Medicine | Q3 | 103 / 167 |
38% |
大類:Medicine 小類:Endocrinology, Diabetes and Metabolism | Q3 | 177 / 244 |
27% |
大類:Medicine 小類:Endocrinology | Q4 | 110 / 128 |
14% |
該(gai)雜志(zhi)是一(yi)本(ben)國(guo)際(ji)優秀雜志(zhi),在國(guo)際(ji)上有較高的學術影響力,行業關(guan)注度很(hen)高,已被國(guo)際(ji)權威數據庫SCIE收錄(lu),該(gai)雜志(zhi)在綜(zong)合(he)專業領域專業度認可(ke)很(hen)高,對稿件內容的創新性和學術性要(yao)求很(hen)高,作為一(yi)本(ben)國(guo)際(ji)優秀雜志(zhi),一(yi)般投(tou)(tou)稿過(guo)審(shen)(shen)時(shi)間都較長,投(tou)(tou)稿過(guo)審(shen)(shen)時(shi)間平均 7 Weeks ,如果想(xiang)投(tou)(tou)稿該(gai)刊要(yao)做好時(shi)間安排。版面(mian)費(fei)不祥。該(gai)雜志(zhi)近兩年未被列入(ru)預警名單,建議您投(tou)(tou)稿。如您想(xiang)了解(jie)更多投(tou)(tou)稿政策及投(tou)(tou)稿方案(an),請咨詢客服。
若用戶需要出版(ban)(ban)服務,請聯系(xi)出版(ban)(ban)商。